Time to make some sense of reimbursement in Europe
This article was originally published in Clinica
Medical device reimbursement and funding policies in Europe are complex and perplexing. They represent a costly, moving target to manufacturers. The following excerpt from a paper given recently by Clinica's European regulatory affairs editor, Amanda Maxwell, at a European conference on Reimbursement*, looks at the problems and possible ways forward.